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INTRODUCTION
Giant cell tumor of the pancreas is a very rare neoplasm and
appears as two different phenotypes: undifferentiated carcino-
ma and osteoclast-like giant cell tumor (OGTP) (1-3). OGTP,
mimicking giant cell tumor of bone should be distinguished
from undifferentiated carcinoma. In contrast to OGTP, undif-
ferentiated carcinoma exhibit more pleomorphic and anaplas-
tic features. OGTP is the more rare type and has a better prog-
nosis than undifferentiated carcinoma (1-3). An implication
of these differences in histological and clinical characteristics
is that these tumors have a different histogenesis. To date,
generally, undifferentiated carcinoma is believed to have an
epithelial origin without debating. However, the histogene-
sis of OGTP remains controversial either epithelial or mes-
enchymal derivation in the literature (4-16). 
Here, we report a case of OGTP, performed the histopatho-
logical, immunohistochemical, ultrastructural, and molecu-
lar biological studies and review the literature pertaining to
this condition. 
CASE REPORT
A 63-yr-old woman was admitted to Chonnam National
University Hospital with a three month history of epigas-
tric pain. Physical examination showed a smooth palpable
mass in the epigastrium. The laboratory examinations were
within normal range. An abdominal computerized tomog-
raphy revealed the presence of a large cystic mass, arising
from the tail of pancreas (Fig. 1A). A distal pancreatectomy
with splenectomy was performed. The resected tumor was a
8×7×6-cm hemorrhagic and cystic mass in the tail of the
pancreas, mimicking pancreatic pseudocyst (Fig. 1B). The
histology confirmed OGTP with ductal adenocarcinoma. She
received third courses of chemotherapy with gemcitabine.
She has been well, without evidence of tumor recurrence 6
months after surgery.
Microscopic findings
Histologically, the tumor was composed of typical ductal
adenocarcinoma and surrounding mononuclear stromal cells
intermingled with osteoclast-like giant cells and pleomorphic
large cells (Fig. 2). The mononuclear cells demonstrated irreg-
ular, pleomorphic nuclei with varying degrees of cytologic
atypia. In contrast, osteoclast-like giant cells had multiple
small uniform nuclei without atypia. Only some pleomor-
phic large cells showed atypical mitoses. In addition, there
was a small area of moderately to well differentiated ductal
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Osteoclast-like giant cell tumor of the pancreas is a very rare neoplasm, of which
the histiogenesis remains controversial. A 63-yr-old woman was hospitalized for
evaluation of epigastric pain. An abdominal computerized tomography revealed
the presence of a large cystic mass, arising from the tail of pancreas. A distal pan-
createctomy with splenectomy was performed. Histologically, the tumor was com-
posed of mononuclear stromal cells intermingled with osteclast-like giant cells. In
addition, there was a small area of moderately to well differentiated ductal adeno-
carcinoma. The final pathologic diagnosis was osteoclast-like giant cell tumor of
the pancreas with ductal adenocarcinoma. Here, we describe the histopathologi-
cal, immunohistochemical, ultrastructural and molecular biological findings of this
tumor with review of the literature pertaining to this condition.
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adenocarcinoma. Frequently cystic degeneration was found
in this tumor.
Immunohistochemical findings
All procedures for immunohistochemical staining were done
by the Micro-Probe staining system (Fisher Scientific, Pitts-
burgh, PA, U.S.A.) based on capillary action (17). Paraffin
sections, of 4  m in thickness with mounted probe on slides,
were immunostained with the panel of primary antibodies
listed Table 1, by the avidin-biotin peroxidase complex method.
The results of immunohistochemical stainings are summa-
rized in Table 2. Immunohistochemically, cytokeratin (CK)
and epithelial membrane antigen (EMA) are strongly posi-
tive for ductal carcinoma cells, whereas both osteoclast-like
giant cells and mononuclear cells were negative for CK (Fig.
3A) and EMA. Osteoclast-like giant cells and mononuclear
cells were positive for histiocytic markers, CD-68 (Fig. 3B)
and lysozyme. In general, immunoreactivity of vimentin was
more intense in pleomorphic large cells than that of osteoclast-
like giant cells and mononuclear cells. Most of the nuclei in
ductal carcinoma cells expressed PCNA, demonstrating intense
proliferative activity, while no nuclei were stained in osteo-
clast-like giant cells and mononuclear cells. Anti-p53 anti-
body did react with some atypical mononuclear cells of weak
intranuclear staining, but did not react with either ductal car-
Fig. 1. (A) An abdominal computerized tomography reveals the presence of a large cystic mass, arising from the tail of pancreas. (B) The
resected tumor is a 8×7×6-cm hemorrhagic and cystic mass in the tail of the pancreas. 
A B
Fig. 2. Histologically, the tumor is composed of typical ductal ade-
nocarcinoma (closed arrow) and surrounding mononuclear stro-
mal cells (open arrow) intermingled with osteoclast-like giant cells
(closed arrow head) and pleomorphic large cells (open arrow
head) (H&E ×200).
CK, cytokeratin; EMA, epithelial membrane antigen; PCNA, proliferating
cell nuclear antigen; M, monclonal antibody; P, polyclonal antibody.
Primary antibody Type Source Dilution
CK M Zymed 1:150
EMA M DAKO 1:75
CD-68 M DAKO 1:50
Lysozyme M Zymed 1:100
Vimentin M Zymed 1:100
PCNA M DAKO 1:100
p53 M Zymed 1:50
Table 1. Primary antibodies used in the immunohistochemical
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cinoma cells or osteoclast-like giant cells.
Electron microscopic findings
For electron microscopy, the tissue specimen was fixed in
2.5% glutaraldehyde, fixed in osmium tetroxide, and embed-
ded in epon mixture. Ultrathin sections, 80 nm in thickness,
were made by LKB-V ultramicrotome with diamond knife,
stained with uranyl acetate and lead citrate, and examined
with a JEM 100CX type II electron microscope. The nucleus
of the mononuclear cell contained prominent nucleoli, with
dispersed clumps of heterochromatin. The cytoplasm con-
tained ample mitochondria, and moderate amount of rough
endoplasmic reticulum (Fig. 4) (Table 2). But we did not find
the evidence of epithelial differentiation including microvil-
Fig. 3. Immunohistochemical staining of cytokeratin (A) and CD-68 (B). Cytokeratin (CK) is strongly positive for ductal carcinoma cells,
whereas both osteoclast-like giant cells and mononuclear cells are negative for CK. However, osteoclast-like giant cells and mononuclear
cells are positive for histiocytic markers, CD-68 (×200).
A B
Fig. 4. Electron microscopically, the nucleus of the mononuclear
cell contains prominent nucleoli, with dispersed clumps of hetero-
chromatin. The cytoplasm contained ample mitochondria, and
moderate amount of rough endoplasmic reticulum (×4,000).
CK, cytokeratin; EMA, epithelial membrane antigen; PCNA, proliferat-











CK + -- -
EMA + -- -
CD-68 - ++ -
Lysozyme - ++ -
Vimentin - ++ +
PCNA + -- -
p53 - + --
Electron microscopy
Mitochondria Abundant Abundant




Codon 12 -- - -
Codon 13 -- - -
Table 2. Results of immunohistochemical, ultrastructural and
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li and desmosomes. In the ultrastructure of multinucleated
osteoclast-like giant cell, there were multiple nuclei with
dispersed chromatin and a fine chromatin rim. The cytoplasm
was characterized by abundant mitochondria of varying size,
free ribosomes, and dilated empty rough endoplasmic retic-
ulum cisternae (Fig. 5) (Table 2).
Molecular biologic findings
To analyze K-ras gene mutations, we microdissected in both
ductal carcinoma and giant cell tumor components separate-
ly. After extracting DNA, polymerase chain reaction (PCR)
amplification and direct sequencing were done to detect K-
ras gene mutation using ABI 3700DNA analyzer. The size
of amplified PCR product was 223 bp. All mutations were
verified in both the sense and anti-sense directions. DNA from
ductal carcinoma with the known K-ras mutation was used
as a positive control. A microdissection method was applied
to allow analyses of K-ras gene mutations as performed by
Sakai et al. (15). However, none of the microdissected osteo-
clast-like giant cell, mononuclear cell, and ductal carcinoma
cell contained K-ras gene mutations at codon 12 (GGT) and
13 (AGT) in our case (Table 2). 
DISCUSSION 
OGTP is very rare and comprises less than 1% of nonen-
docrine pancreatic tumor (1-3). To date, only two cases have
been reported in Korea (18, 19). In the review of English liter-
ature (20-22), OGTP tends to present in the 7th decade of
life, although younger patients have been reported. There was
no sex preference. The main symptoms and signs were abdomi-
nal pain, palpable mass, weight loss and jaundice. OGTP
commonly exhibited as large cystic neoplasms with hemor-
rhage and necrosis of variable extent. There was predilection
to involve head and body portion of the pancreas. The prog-
nosis of OGTP is better than that of pancreatic ductal ade-
nocarcinoma and undifferentiated carcinoma, suggesting that
OGTP grows more slowly and is less likely to metastasize
than pancreatic ductal adenocarcinoma and undifferentiated
carcinoma. However, the outcome of OGTP is extremely vari-
able in the literature. Although it is difficult to decide treat-
ment modality because of its rarity, the choice of treatment
of OGTP may be surgical resection if possible. Also, in pre-
vious reports, experience of adjuvant treatments including
chemotherapy or radiotherapy was not described, so no detailed
information was provided. However, because the outcome
of OGTP is extremely variable, it may be reasonable to con-
sider adjuvant treatment for prevention of tumor recurrence.
In our case, we did attempt chemotherapy with gemcitabine,
according to treatment protocol established for pancreatic
ductal adenocarcinoma. We think that this attempt is impor-
tant and necessary to detail the treatment modalities and clini-
cal outcome.
Although the histiogenesis of OGTP has been previously
investigated by immunohistochemical, ultrastructural, and
molecular biologic studies, the origin of these cells is still con-
troversial.
In our case, osteoclast-like giant cells and mononuclear cells
were positive for histiocytic markers, CD68 and lysozyme
in contrast to negative for epithelial markers, CK and EMA.
In the ultrastructure of multinucleated, osteoclast-like giant
cells and mononuclear cells, we did not find either microvilli
or desmosomes for the clue of epithelial differentiation.
Tumor progression is regulated by many biological pro-
cesses including cell proliferation and genetic alterations of
tumor suppressor gene and oncogene. PCNA reflects cell pro-
liferation and mutation of the p53 tumor suppressor gene
represents one of the common genetic alterations in pancre-
atic ductal carcinoma. In our case, ductal carcinoma cells ex-
pressed PCNA while no nuclei were stained in osteoclast-
like giant cells and mononuclear cells. p53 immunoreactivi-
ty showed only weak intranuclear staining in some atypical
mononuclear cells, but did not show in ductal carcinoma cells
and osteoclast-like giant cells.
K-ras gene mutations are a hallmark of pancreatic ductal
carcinoma and appear to be present in 80% to 90% of tumors.
Evidence of K-ras gene mutations indicates that its origin is
an epithelial nature. But in our case, none of the microdis-
sected osteoclast-like giant cell, mononuclear cell, and duc-
tal carcinoma cell contained K-ras gene mutations.
These results may support that both osteoclast-like giant
Fig. 5. Electron microscopically, osteoclast-like giant cell has mul-
tiple nuclei with dispersed chromatin and a fine chromatin rim. The
cytoplasm is characterized by abundant mitochondria of varying
size, free ribosomes, and dilated empty rough endoplasmic retic-
ulum cisternae (×4,000).520 Y.-E. Joo, T. Heo, C.-H. Park, et al.
cells and mononuclear cells in OGTP originate from mes-
enchymal rather than epithelial cell. However, although most
reports have debated the histiogenesis of OGTP from immuno-
histochemical, ultrastructural, and molecular biologic as-
pects, it is still obscure whether the histiogenesis of OGTP
is epithelial or mesenchymal origin (4-16). There are several
possible explanations for these discrepancies. First, OGTP is
too rare to discern differences in the origin of these cells. Sec-
ond, immunohistochemical staining methods and primary
antibodies used are different in different cases (4). Third,
OGTP can express different phenotypes with variable stages
and degrees of differentiation during tumor progression (4,
23). Fourth, circulating precursor cell may be stimulated by
tumor derived factors such as cytokines, to proliferate and
differentiate into different cell types (4, 16, 20, 21). 
Clinical characteristics and histiogenesis of OGTP are still
now variable and controversial in the literature. Therefore,
further studies based on a large populations are necessary to
clarify its histiogenesis. 
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